A transmembrane domain heterodimer, acting in concert with a membrane-proximal cytoplasmic domain clasp, is thought to maintain integrins in a low affinity state. To test whether helix-helix interactions between the ␣IIb and 3 transmembrane domains regulate the activity of integrin ␣IIb3, we synthesized a soluble peptide corresponding to the ␣IIb transmembrane domain, designated ␣IIb-TM, and we studied its ability to affect ␣IIb3 activity in human platelets. ␣IIb-TM was ␣-helical in detergent micelles and phospholipid vesicles, readily inserted into membrane bilayers, bound to intact purified ␣IIb3, and specifically associated with the transmembrane domain of ␣IIb, rather than the transmembrane domains of 3, ␣2, and 1, other integrin subunits present in platelets. When added to suspensions of gel-filtered platelets, ␣IIb-TM rapidly induced platelet aggregation that was not inhibited by preincubating platelets with the prostaglandin E 1 or the ADP scavenger apyrase but was prevented by the divalent cation chelator EDTA. Furthermore, ␣IIb-TM induced fibrinogen binding to platelets but not the binding of osteopontin, a specific ligand for platelet ␣v3. The peptide also induced fibrinogen binding to recombinant ␣IIb3 expressed by Chinese hamster ovary cells, confirming that its effect was independent of platelet signal transduction. Finally, transmission electron microscopy of purified ␣IIb3 revealed that ␣IIb-TM shifted the integrin from a closed configuration with its stalks touching to an open configuration with separated stalks. These observations demonstrate that transmembrane domain interactions regulate integrin function in situ and that it is possible to target intra-membranous protein-protein interactions in a way that can have functional consequences.The affinity of integrins for ligands appears to be regulated by interactions between the transmembrane (TM) 2 and/or cytoplasmic domains of their ␣ and  subunits (1). Thus, it is likely that a TM domain heterodimer, acting in concert with a membrane-proximal cytoplasmic domain clasp, maintains integrins in a low affinity state. The prototypic example of integrin regulation is platelet ␣IIb3. ␣IIb3, a receptor for the plasma proteins fibrinogen, von Willebrand factor, fibronectin, and vitronectin is maintained in an inactive state on circulating platelets, but following vascular trauma, it shifts allosterically to an active conformation, a prelude to the formation of hemostatic platelet aggregates (1). Data supporting the heteromeric association of the ␣IIb and 3 TM domains in unstimulated platelets are largely indirect (2, 3). Moreover, proteins containing these domains also associate homomerically in micelles and bacterial membranes (4, 5). It is noteworthy that mutations that either enhance or disrupt homomeric ␣IIb and 3 TM domain interactions in vitro can activate the intact integrin expressed in Chinese hamster ovary (CHO) cells. These observations suggest a "push-pull" mechanism for ␣IIb3 regulation in which processes that destabilize het...